Livzon Pharmaceutical Group announces A-share repurchases

Livzon Pharmaceutical Group has filed its next day disclosure report, detailing share repurchases of its A-shares on the Shenzhen Stock Exchange. As of September 4, 2025, the company's total issued H-shares remained at 299,807,117, with no changes reported for this share class. For A-shares, the total issued shares stood at 604,293,313 as of September 3, 2025.

On September 4, 2025, Livzon Pharmaceutical Group repurchased 72,900 A-shares through the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from RMB 40.22 to RMB 41.84 per share, totaling an aggregate payment of RMB 2,997,844. These 72,900 repurchased A-shares are intended for cancellation, bringing the total number of A-shares for cancellation to 72,900.

Following these latest transactions, the number of issued A-shares remained at 604,293,313 as of September 4, 2025. The company confirmed that all repurchases were conducted in accordance with the listing rules and internal authorizations, with the repurchase mandate approved on April 24, 2025.